论文部分内容阅读
目的探讨普米克令舒联合博利康尼氧气雾化吸入治疗小儿毛细支气管炎的临床效果。方法我远自2010年8月至2012年8月收治毛细支气管炎患儿94例,随机分为治疗组和对照组,每组各47例,治疗组患儿给予普米克令舒联合博利康尼氧气雾化吸入治疗,对照组患儿给予常规地塞米松磷酸钠静脉滴注治疗,观察两组患儿临床症状改善情况,统计两组患儿的实际临床治疗效果。结果治疗组显效25例,有效21例,无效1例,总有效率为97.87%;对照组显效14例,有效24例,无效9例,总有效率为80.85%。结论普米克令舒联合博利康尼氧气雾化吸入治疗小儿毛细支气管炎临床效果显著,值得推广应用。
Objective To investigate the clinical effect of pulmicort and combiblocconazole inhalation on children bronchiolitis. Methods I far from 94 patients with bronchiolitis admitted from August 2010 to August 2012, were randomly divided into treatment group and control group, 47 cases in each group, the treatment group given Pulmicort Respules combined with Boli Kang Ni Oxygen atomization inhalation therapy, the control group of children given conventional dexamethasone sodium phosphate intravenous infusion treatment to observe the improvement of clinical symptoms in two groups of children, statistics of the actual clinical treatment of children in both groups. Results In the treatment group, 25 cases were markedly effective, 21 cases were effective, 1 case was ineffective, and the total effective rate was 97.87%. In the control group, 14 cases were markedly effective, 24 cases were effective and 9 cases were ineffective. The total effective rate was 80.85%. Conclusion Pulmicort respules combiblipanib aerosol inhalation treatment of children with bronchiolitis significant clinical effect, it is worth promoting the application.